HealthyDirect · GrowthFit for a long SIP
HDFC INNOVATION FUND
HDFC Mutual FundEquity Scheme - Sectoral/ Thematic1.3 years
The scheme seeks to generate long-term capital appreciation / income by investing in companies that are adopting innovative themes and strategies. There is no assurance that the investment objective of the scheme will be achieved.
- NAV
- 11.521
- 30 Oct 2026
- 1Y
- +10.0%
- Trailing CAGR
- Upside capture
- +144%
- Vs NIFTY 500 TRI
- Downside capture
- +65%
- Lower is better
Buying brief
Should you add this fund?
Evidence on this desk, framed as a purchase checklist - not SEBI-registered advice.
As of 30 Oct 2026
Stance
Fit for a long SIP
Evidence supports keeping this on a shortlist for a multi-year equity SIP.
In three lines
Fits if · The fund beat the category median in 100% of rolling 1-year windows.
Fits if · Peak-to-trough drawdown has stayed shallower than 15%.
Buy checklist
History depth
Fail
1.3 years - thin for judging consistency.
Engine status
Pass
Evidence supports keeping this on a shortlist for a multi-year equity SIP.
Expense ratio
Pass
1.02% TER (Direct). Lower cost compounds on long SIPs.
Drawdown vs peers
Pass
Peak-to-trough -12.3%. Ask whether you can hold through a similar fall.
Vs category
n/a
Category relative read still thin.
Manager tenure
Watch
Amit Sinha · 1.3 years on the scheme.
Exit load
n/a
No exit-load summary on file.
Tax / wrapper
Pass
Direct Growth, no ELSS lock flagged. Equity LTCG rules still apply after one year - not tax advice.
Portfolio concentration
Pass
Top 10 holdings ≈ 38.7% of the portfolio.
Evidence supports a shortlist - confirm with peers before you buy elsewhere.
Before you buy or SIP
Behaviour and wrappers - the usual India MF failure modes - not a buy instruction.
Drawdown rehearsal
This scheme’s worst fall on file is about 12%. Before you SIP, ask whether you would keep contributing through a similar drop - pausing on fear is the usual India MF failure mode.
SIP discipline
If you start a SIP here, diary a 90-day check and an annual review - don’t react to every NAV print.
NAV
Path not in current snapshots
n/a
Returns
Trailing CAGR and simulated monthly SIP XIRR from daily NAV. Category comparison uses the median of comparable share classes in the peer set.
Trailing CAGR
Point-to-point, calendar-day annualized
- 1Y+10.0%
- 3Yn/a
- 5Yn/a
- 10Yn/a
- SI+11.5%
SIP XIRR
Equal monthly instalments to latest NAV
- 1Y+17.7%
- 3Yn/a
- 5Yn/a
- 10Yn/a
- Since inception
- +11.5%
- Calendar-day CAGR
- Excess 1Y
- +12.4%
- Category median, same plan and option
- 3Y win rate
- n/a
- Windows beating the median
- 3Y percentile
- n/a
- Vs comparable share classes
- SIP 3Y XIRR
- n/a
- Simulated monthly SIP
- Worst rolling 3Y
- n/a
- 0 daily-ending windows
- Median rolling 3Y
- n/a
- Calendar-day CAGR
- Positive rolling 5Y
- n/a
- 0 daily-ending windows
Official benchmark
Date-aligned against NIFTY 500 TRI. Capture ratios use common month-end observations through 30 Oct 2026.
- 1Y excess
- +17.3%
- Fund minus TRI
- 3Y excess
- n/a
- Fund minus TRI
- Upside capture
- +144%
- Benchmark-up months
- Downside capture
- +65%
- Lower is better
Drawdown
Peak to trough from a running NAV high, with the path and recovery episodes.
- Max drawdown
- -12.3%
- Worst peak-to-trough
- Current
- -5.5%
- Below last peak
- Current spell
- 37 days
- Days below latest peak
- Time below peak
- +84%
- NAV observations
Drawdown
Path not in current snapshots
n/a
- Average recovery
- 8 days
- 21 recovered episodes
- Longest recovery
- 52 days
- Trough to prior peak
17 Nov 2025 – 6 May 2026
Trough 31 Mar 2026 · recovered in 36 days
-12.3%
23 Sept 2026 – open
Trough 23 Oct 2026 · not recovered
-9.5%
19 Sept 2025 – 17 Nov 2025
Trough 26 Sept 2025 · recovered in 52 days
-5.0%
23 Jul 2025 – 21 Aug 2025
Trough 8 Aug 2025 · recovered in 13 days
-4.2%
Dimensions
0–100 reads of named metrics. The mean is unweighted and only uses dimensions with data.
Returns
44
Vs category
100
Consistency
100
Risk-adjusted
47
Drawdown
69
Mean
72
Decision
Quantitative engine reasons behind the buying stance. An explanation can only restate what is already here.
Healthy
Buying stance
Fit for a long SIP
Evidence supports keeping this on a shortlist for a multi-year equity SIP.
Why this status
- No material deterioration, cost shock, or persistent category underperformance in the current evidence set.
Supporting reads
- The fund beat the category median in 100% of rolling 1-year windows.
- Peak-to-trough drawdown has stayed shallower than 15%.
Portfolio
30 Sept 2026 · 81 holdings · top 10 are 38.7%.
- Top 5
- 24.7%
- Top 10
- 38.7%
- Largest holding
- 9.2%
- Effective holdings
- 38.4
Zomato Ltd
Technology
9.2%
Repo
Unspecified
5.0%
Bajaj Finance Ltd
Financial
4.0%
Divi's Laboratories Ltd
Healthcare
3.3%
Rubicon Research Ltd.
Healthcare
3.2%
What changed
PERFORMANCE
Recent rolling excess versus the category median has deteriorated.
16 Oct 2026
Worth investigating
Same-category peers with enough history to inspect beside this fund - including tradeoffs.
Kotak Business Cycle Fund
Kotak Mahindra Mutual Fund
- 1Y
- -0.1%
- 3Y
- +15.8%
- Vol
- 12.7%
- Max DD
- -18.4%
- Sharpe
- 0.70
- 3Y win
- +98%
- Lower volatility
- Lower TER
- Higher trailing returns
Caveat: Deeper drawdown
Aditya Birla Sun Life Business Cycle Fund
Aditya Birla Sun Life Mutual Fund
- 1Y
- -0.1%
- 3Y
- +12.7%
- Vol
- 13.9%
- Max DD
- -17.8%
- Sharpe
- 0.38
- 3Y win
- +13%
- Lower volatility
- Higher trailing returns
Caveat: Deeper drawdown · Higher TER
ICICI PRUDENTIAL HOUSING OPPORTUNITIES FUND
ICICI Prudential Mutual Fund
- 1Y
- -9.5%
- 3Y
- +10.3%
- Vol
- 12.6%
- Max DD
- -16.7%
- Sharpe
- 0.54
- 3Y win
- +65%
- Lower volatility
- Higher trailing returns
Caveat: Deeper drawdown · Higher TER
Nippon India Innovation Fund
Nippon India Mutual Fund
- 1Y
- -5.1%
- 3Y
- +12.8%
- Vol
- 14.3%
- Max DD
- -21.5%
- Sharpe
- 0.46
- 3Y win
- +100%
- Lower TER
- Higher trailing returns
Caveat: Higher volatility · Deeper drawdown
Aditya Birla Sun Life Commodity Equities Fund - Global Agri Plan
Aditya Birla Sun Life Mutual Fund
- 1Y
- -2.5%
- 3Y
- +20.3%
- Vol
- 16.8%
- Max DD
- -42.2%
- Sharpe
- 0.16
- 3Y win
- n/a
- Higher trailing returns
Caveat: Higher volatility · Deeper drawdown